Dosen af PegIntron i monoterapi bør reduceres hos patienter med moderat eller kraftigt nedsat nyrefunktion (se pkt.
67 for monotherapy should be reduced in patients with moderate or severe renal impairment (see sections 4.2 and 4.4).